Hyundai Pharmaceutical Co., Ltd. (KRX:004310)
10,070
-430 (-4.10%)
Sep 18, 2026, 3:30 PM KST
| Market Cap | 278.71B +152.7% |
| Revenue (ttm) | 108.14B +5.8% |
| Net Income | 1.41B |
| EPS | 60.34 |
| Shares Out | 27.68M |
| PE Ratio | 166.89 |
| Forward PE | n/a |
| Dividend | 30.00 (0.30%) |
| Ex-Dividend Date | Mar 3, 2026 |
| Volume | 3,709,711 |
| Open | 10,650 |
| Previous Close | 10,500 |
| Day's Range | 10,030 - 10,710 |
| 52-Week Range | 3,500 - 15,960 |
| Beta | 0.72 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |